Phibro Animal Health Corporation (PAHC)
US — Healthcare Sector
Automate Your Wheel Strategy on PAHC
With Tiblio's Option Bot, you can configure your own wheel strategy including PAHC - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol PAHC
- Rev/Share 29.3996
- Book/Share 6.5677
- PB 4.2648
- Debt/Equity 2.8949
- CurrentRatio 2.9121
- ROIC 0.0522
- MktCap 1135346360.0
- FreeCF/Share 1.2113
- PFCF 23.1429
- PE 35.6821
- Debt/Assets 0.5846
- DivYield 0.0171
- ROE 0.1237
- Rating C+
- Score 2
- Recommendation Sell
- P/E Score 2
- DCF Score 1
- P/B Score 2
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Upgrade | PAHC | JP Morgan | Neutral | Overweight | -- | $35 | July 7, 2025 |
| Upgrade | PAHC | BNP Paribas Exane | Underperform | Neutral | -- | $24 | June 16, 2025 |
| Initiation | PAHC | JP Morgan | -- | Neutral | -- | $22 | Sept. 10, 2024 |
News
4 Stocks Trading Near 52-Week High With More Upside Potential
C,
ENS,
NFG,
PAHC
Published: February 14, 2025 by: Zacks Investment Research
Sentiment: Positive
Published: February 14, 2025 by: Zacks Investment Research
Sentiment: Positive
Stocks like NFG, ENS, PAHC and C are seeing price strength and have a high chance of carrying the momentum forward.
Read More
New Strong Buy Stocks for February 14th
ATGE,
FINW,
FRSH,
PAHC,
SFTBY
Published: February 14, 2025 by: Zacks Investment Research
Sentiment: Positive
Published: February 14, 2025 by: Zacks Investment Research
Sentiment: Positive
FRSH, SFTBY, ATGE, FINW and PAHC have been added to the Zacks Rank #1 (Strong Buy) List on February 14, 2025.
Read More
Best Value Stocks to Buy for February 14th
ATGE,
PAHC
Published: February 14, 2025 by: Zacks Investment Research
Sentiment: Positive
Published: February 14, 2025 by: Zacks Investment Research
Sentiment: Positive
ATGE and PAHC made it to the Zacks Rank #1 (Strong Buy) value stocks list on February 14, 2025.
Read More
Best Income Stocks to Buy for February 14th
PAHC
Published: February 14, 2025 by: Zacks Investment Research
Sentiment: Positive
Published: February 14, 2025 by: Zacks Investment Research
Sentiment: Positive
PAHC made it to the Zacks Rank #1 (Strong Buy) income stocks list on February 14, 2025.
Read More
Phibro Animal Health (PAHC) Is Up 8.62% in One Week: What You Should Know
PAHC
Published: February 11, 2025 by: Zacks Investment Research
Sentiment: Positive
Published: February 11, 2025 by: Zacks Investment Research
Sentiment: Positive
Does Phibro Animal Health (PAHC) have what it takes to be a top stock pick for momentum investors? Let's find out.
Read More
Is Phibro (PAHC) a Solid Growth Stock? 3 Reasons to Think "Yes"
PAHC
Published: February 10, 2025 by: Zacks Investment Research
Sentiment: Positive
Published: February 10, 2025 by: Zacks Investment Research
Sentiment: Positive
Phibro (PAHC) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Read More
About Phibro Animal Health Corporation (PAHC)
- IPO Date 2014-04-11
- Website https://www.pahc.com
- Industry Drug Manufacturers - Specialty & Generic
- CEO Jack Clifford Bendheim
- Employees 1940
Phibro Animal Health Corporation develops, manufactures, and supplies a range of animal health and mineral nutrition products for livestock primarily in the United States. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for a range of food animals, including poultry, swine, beef and dairy cattle, and aquaculture. Its animal health products also comprise antibacterials that are biological or chemical products used in the animal health industry to treat or to prevent bacterial diseases; anticoccidials primarily used to prevent and control the disease coccidiosis in poultry and cattle; anthelmintics to treat infestations of parasitic intestinal worms; and anti-bloat treatment products for cattle to control bloat in animals grazing on legume or wheat-pasture. In addition, the company offers nutritional specialty products, which enhance nutrition to help improve health and performance; and vaccines to prevent diseases primarily for the poultry and swine markets. Further, it manufactures and markets formulations and concentrations of trace minerals, such as zinc, manganese, copper, iron, and other compounds; and various specialty ingredients for use in the personal care, industrial chemical, and chemical catalyst industries. The company sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle integrators, as well as through commercial animal feed manufacturers, wholesalers, and distributors. It operates in the United States, Latin America, Canada, Europe, the Middle East, Africa, and the Asia Pacific. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. Phibro Animal Health Corporation was incorporated in 2014 and is headquartered in Teaneck, New Jersey.